Skip to main content

Advertisement

SpringerLink
Log in

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Endotoxin is a component of the outer membrane of gram-negative bacteria that live in the intestine. Endotoxinemia is reported in non-alcoholic fatty liver disease and in cirrhotic patients, causing various biological and clinical effects in the host. It is not known whether endotoxinemia occurs in chronic hepatitis C patients (CHC), therefore we evaluated the occurrence of endotoxinemia and its effect on inflammation, liver damage, insulin resistance (IR) and atherosclerosis.

Methods

Consecutive CHC patients assessed by liver biopsy were enrolled. Endotoxinemia was evaluated by LAL test. IR was estimated by HOMA-IR. Serum TNF-α, IL-8, adiponectin and MCP-1 were measured with ELISA tests. Oxidative stress was estimated by circulating IgG against malondialdehyde adducts with human serum albumin (MDA-HAS). Carotid atherosclerosis was assessed by ultrasonography.

Results

Endotoxinemia was found in 60% of the 126 patients enrolled. A serum level-dependent association between endotoxinemia, steatosis (p < 0.001) and HOMA-IR (p < 0.006) was observed. Patients with endotoxinemia showed significant increase in TNF-α and IL8 levels. TNF-α correlated with steatosis (p <  0.001) and HOMA-IR (p < 0.03), whereas IL8 correlated with steatosis (p =  <0.001), TNF-α (p < 0.04) and atherosclerosis (p < 0.01). The highest levels of endotoxinemia were associated with oxidative stress and a higher prevalence of carotid atherosclerosis. Multivariate logistic regression analysis showed that the independent factors associated with endotoxinemia were hepatic steatosis, HOMA-IR, IL8 and MDA-HAS.

Conclusions

Endotoxinemia occurs with high frequency in CHC patients and contributes to the development of hepatic steatosis, IR and atherosclerosis through increased pro-inflammatory cytokines and oxidative stress. Anti-endotoxin treatment could be of clinical relevance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Glaros TG, Chang S, Gilliam EA, Maitra U, Deng H, Li L. Causes and consequences of low grade endotoxemia and inflammatory diseases. Front Biosci. 2013;5:754–65.

    Article  Google Scholar 

  2. Gaeta GB, Perna P, Adinolfi LE, et al. Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance. Digestion. 1982;23:239–44.

    Article  CAS  Google Scholar 

  3. Pascual S, Such J, Esteban A, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology. 2003;50:1482–86.

    PubMed  Google Scholar 

  4. Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012;142:1100–101.

    Article  CAS  Google Scholar 

  5. Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452–55.

    Article  CAS  Google Scholar 

  6. Yuan J, Baker SS, Liu W, et al. Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2014;29:1292–8.

    Article  CAS  Google Scholar 

  7. Anderson PD, Mehta NN, Wolfe ML, et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab. 2007;92:2272–279.

    Article  CAS  Google Scholar 

  8. Boroni Moreira AP, de Cássia Gonçalves Alfenas R. The influence of endotoxemia on the molecular mechanisms of insulin resistance. Nutr Hosp. 2012;27:382–90.

    CAS  PubMed  Google Scholar 

  9. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358–364.

    Article  CAS  Google Scholar 

  10. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126:586–97.

    Article  CAS  Google Scholar 

  11. Adinolfi LE, Restivo L, Zampino R, et al. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis. 2012;221:496–502.

    Article  CAS  Google Scholar 

  12. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–99.

    Article  CAS  Google Scholar 

  13. Vidali M, Tripodi MF, Ivaldi A, et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol. 2008;48:399–406.

    Article  CAS  Google Scholar 

  14. Tsui JI, Whooley MA, Monto A, Seal K, Tien PC, Shlipak M. Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail. 2009;15:451–56.

    Article  CAS  Google Scholar 

  15. Oliveira CP, Kappel CR, Siqueira ER, et al. Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol. 2013;164:221–26.

    Article  CAS  Google Scholar 

  16. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.

    Article  CAS  Google Scholar 

  17. Sakaguchi S, Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Pathog Dis. 2006;47:167–77.

    CAS  Google Scholar 

  18. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009;51:212–23.

    Article  CAS  Google Scholar 

  19. Rabelo F, Oliveira CP, Faintuch J, et al. Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg. 2010;20:906–12.

    Article  Google Scholar 

  20. Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–887.

    Article  CAS  Google Scholar 

  21. Brun P, Castagliuolo I, Pinzani M, Palù G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2005;289:G571–8.

    Article  CAS  Google Scholar 

  22. Schnabl B, Brandl K, Fink M, et al. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2008;375:210–14.

    Article  CAS  Google Scholar 

  23. Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–85.

    Article  CAS  Google Scholar 

  24. Ceccarelli S, Panera N, Mina M, et al. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease. Oncotarget. 2015;6:41434–52.

    Article  Google Scholar 

  25. Ruiz AG, Casafont F, Crespo J, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007;17:1374–380.

    Article  Google Scholar 

  26. Durante-Mangoni E, Zampino R, Marrone A, et al. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Aliment Pharmacol Ther. 2006;24:1349–457.

    Article  CAS  Google Scholar 

  27. Ashour E, Samy N, Sayed M, Imam A. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4. Clin Lab. 2010;56:103–10.

    CAS  PubMed  Google Scholar 

  28. Dolganiuc A, Norkina O, Kodys K, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007;133:1627–636.

    Article  CAS  Google Scholar 

  29. Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. 2011;141:1220–230.

    Article  Google Scholar 

  30. Sakaguchi S, Furusawa S. Oxidative stress and septic shock. FEMS Immunol Med Microbiol. 2006;47:167–77.

    Article  CAS  Google Scholar 

  31. González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Hepatitis C, Virus. Oxidative stress and steatosis: current status and perspectives. Curr Mol Med. 2011;11:373–90.

    Article  Google Scholar 

  32. Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Non-alcoholic fatty liver disease: evolving paradigms. World J Gastroenterol. 2017;23:6571–92.

    Article  Google Scholar 

  33. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 2007;27:84–91.

    Article  CAS  Google Scholar 

  34. Carreau A, Kieda C, Grillon C. Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment. Exp Cell Res. 2011;317:29–41.

    Article  CAS  Google Scholar 

  35. Xi H, Akishita M, Nagai K, et al. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis. 2007;191:281–89.

    Article  CAS  Google Scholar 

  36. Remick GD. Interleukin-8. Crit Care Med. 2005;33:s646–s647.

    Article  Google Scholar 

  37. De Forg LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem. 1993;268:568–76.

    Google Scholar 

  38. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009;84:353–60.

    Article  CAS  Google Scholar 

  39. Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol. 1999;29:700–12.

    Article  CAS  Google Scholar 

  40. Simonini A, Moscucci M, Muller DWM, et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 2000;101:1519–26.

    Article  CAS  Google Scholar 

  41. Ait-Belgnaoui A, Durand H, Cartier C, et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012;37:1885–95.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical, Surgical, Neurological, Metabolic, and Aging Sciences, University of Campania “L. Vanvitelli”, Piazza Miraglia, 80138, Naples, Italy

    Rosa Zampino, Aldo Marrone, Luca Rinaldi, Barbara Guerrera, Riccardo Nevola, Adriana Boemio, Natalina Iuliano, Mauro Giordano, Nicola Passariello, Ferdinando C. Sasso & Luigi E. Adinolfi

  2. Department of Health Sciences and Interdisciplinary Research Center for Autoimmune Diseases, University Amedeo Avogadro of East Piedmont, Novara, Italy

    Emanuele Albano

Authors
  1. Rosa Zampino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aldo Marrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luca Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Barbara Guerrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Riccardo Nevola
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adriana Boemio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Natalina Iuliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mauro Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nicola Passariello
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ferdinando C. Sasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Emanuele Albano
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Luigi E. Adinolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luigi E. Adinolfi.

Ethics declarations

Conflict of interest

There are none to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zampino, R., Marrone, A., Rinaldi, L. et al. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection 46, 793–799 (2018). https://doi.org/10.1007/s15010-018-1185-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-018-1185-6

Keywords

Search

Navigation